Examples of 'efalizumab' in a sentence
Meaning of "efalizumab"
Efalizumab is a monoclonal antibody that was used to treat autoimmune diseases like psoriasis
Show more definitions
- A recombinant humanized monoclonal antibody, formerly available to treat autoimmune diseases, especially psoriasis, by binding CD11a of lymphocyte function-associated antigen 1, and associated with fatal brain infections.
How to use "efalizumab" in a sentence
Basic
Advanced
efalizumab
It is possible that efalizumab is excreted in human milk.
Efalizumab is cleared by nonlinear saturable elimination dose dependent.
Hypersensitivity to efalizumab or to any of the excipients.
It is the target of the drug efalizumab.
The pharmacokinetics of efalizumab in paediatric patients have not been studied.
Weight is the most significant covariate affecting efalizumab clearance.
Efalizumab is a monoclonal antibody.
There are no adequate data from the use of efalizumab in pregnant women.
Efalizumab is intended for use under the guidance and supervision of a practitioner.
Efficacy results were evaluated based on the pivotal studies conducted with efalizumab manufactured by Genentech.
Efalizumab or Raptiva has been used at this point in children as well.
Powder for solution for injection Efalizumab.
The efalizumab used in the study is the Genentech manufactured product.
Two drugs that target T cells are efalizumab and alefacept.
Otherwise, the effects observed in non-clinical studies could be related to the pharmacology of efalizumab.
See also
Moreover, an antibody analogue of efalizumab was shown to be excreted in milk of mice.
In one embodiment, the antibody is efalizumab.
After subcutaneous administration of efalizumab peak plasma concentrations are reached after 12 days.
Through population pharmacokinetic analysis, weight was found to affect efalizumab clearance.
If you are allergic ( hypersensitive ) to efalizumab or any of the other ingredients of Raptiva.
Modulating agents acting on T cells, alfacept and efalizumab.
Efalizumab is a recombinant humanized monoclonal antibody produced in genetically engineered Chinese Hamster Ovary ( CHO ) cells.
Two medications that target T cells are efalizumab and alefacept.
Antibodies to efalizumab were detected in only 6 % of patients evaluated.
One vial of powder contains a retrievable amount of 125 mg of efalizumab.
The active substance is efalizumab, each vial contains a deliverable dose of 125 mg efalizumab.
Cytochrome P450 enzymes as well as conjugation reactions are not involved in the metabolism of efalizumab.
Efalizumab does not cross-react with CD11a from species other than humans and chimpanzees.
Adalimumab, etanercept, infliximab, and efalizumab were part of these DO.
Efalizumab ( trade name Raptiva, Genentech, Merck Serono ) is a recombinant humanized monoclonal antibody.
The active ingredient of RAPTIVA is efalizumab ( eh fah LIH zyoo mab ).
Efalizumab binds to the CD11a subunit of lymphocyte function-associated antigen 1.
Each vial contains a retrievable amount of 125 mg of efalizumab.
By preventing LFA-1/ICAM binding, efalizumab may alleviate signs and symptoms of psoriasis by inhibiting several.
Reconstitution with the solvent yields a solution containing efalizumab at 100 mg / ml.
Of efalizumab (Xoma and Genentech).
Raptiva 100 mg / ml powder and solvent for solution for injection Efalizumab.
Efalizumab was voluntarily withdrawn from the US market in April, 2009 by the manufacturer.
Raptiva 100 mg / ml Powder for solution for injection Efalizumab Subcutaneous use.
Efalizumab was approved for the treatment of PSO in the USA and Europe in 2003.
